BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17712362)

  • 1. Antiangiogenic therapy for normalization of atherosclerotic plaque vasculature: a potential strategy for plaque stabilization.
    Jain RK; Finn AV; Kolodgie FD; Gold HK; Virmani R
    Nat Clin Pract Cardiovasc Med; 2007 Sep; 4(9):491-502. PubMed ID: 17712362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elimination of neoangiogenesis for plaque stabilization: is there a role for local drug therapy?
    Kolodgie FD; Narula J; Yuan C; Burke AP; Finn AV; Virmani R
    J Am Coll Cardiol; 2007 May; 49(21):2093-101. PubMed ID: 17531658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage.
    Virmani R; Kolodgie FD; Burke AP; Finn AV; Gold HK; Tulenko TN; Wrenn SP; Narula J
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2054-61. PubMed ID: 16037567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenesis as risk factor for plaque vulnerability.
    Di Stefano R; Felice F; Balbarini A
    Curr Pharm Des; 2009; 15(10):1095-106. PubMed ID: 19355951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plaque neovascularization and antiangiogenic therapy for atherosclerosis.
    Doyle B; Caplice N
    J Am Coll Cardiol; 2007 May; 49(21):2073-80. PubMed ID: 17531655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do plaques rapidly progress prior to myocardial infarction? The interplay between plaque vulnerability and progression.
    Ahmadi A; Leipsic J; Blankstein R; Taylor C; Hecht H; Stone GW; Narula J
    Circ Res; 2015 Jun; 117(1):99-104. PubMed ID: 26089367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth factor therapy in atherosclerotic disease-friend or foe.
    Hoefer IE; Timmers L; Piek JJ
    Curr Pharm Des; 2007; 13(17):1803-10. PubMed ID: 17584109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of neovascularization and intraplaque haemorrhage to atherosclerotic plaque progression and instability.
    Chistiakov DA; Orekhov AN; Bobryshev YV
    Acta Physiol (Oxf); 2015 Mar; 213(3):539-53. PubMed ID: 25515699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathology of plaque haemorrhage and neovascularization of coronary artery.
    Kodama T; Narula N; Agozzino M; Arbustini E
    J Cardiovasc Med (Hagerstown); 2012 Oct; 13(10):620-7. PubMed ID: 22828775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraplaque hemorrhage and progression of coronary atheroma.
    Kolodgie FD; Gold HK; Burke AP; Fowler DR; Kruth HS; Weber DK; Farb A; Guerrero LJ; Hayase M; Kutys R; Narula J; Finn AV; Virmani R
    N Engl J Med; 2003 Dec; 349(24):2316-25. PubMed ID: 14668457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New understanding of the onset of atherosclerosis--angiogenesis and hypoxia play a crucial role].
    Sluimer JC; Daemen MJ
    Ned Tijdschr Geneeskd; 2009; 153():A847. PubMed ID: 20015418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on acute coronary syndromes: the pathologists' view.
    Falk E; Nakano M; Bentzon JF; Finn AV; Virmani R
    Eur Heart J; 2013 Mar; 34(10):719-28. PubMed ID: 23242196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of lipids and intraplaque hypoxia in the formation of neovascularization in atherosclerosis.
    Chistiakov DA; Melnichenko AA; Myasoedova VA; Grechko AV; Orekhov AN
    Ann Med; 2017 Dec; 49(8):661-677. PubMed ID: 28797175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mathematical modeling of atherosclerotic plaque destabilization: Role of neovascularization and intraplaque hemorrhage.
    Guo M; Cai Y; Yao X; Li Z
    J Theor Biol; 2018 Aug; 450():53-65. PubMed ID: 29704490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free cholesterol in atherosclerotic plaques: where does it come from?
    Kolodgie FD; Burke AP; Nakazawa G; Cheng Q; Xu X; Virmani R
    Curr Opin Lipidol; 2007 Oct; 18(5):500-7. PubMed ID: 17885419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocytic myocarditis occurs with myocardial infarction and coincides with increased inflammation, hemorrhage and instability in coronary artery atherosclerotic plaques.
    Woudstra L; Biesbroek PS; Emmens RW; Heymans S; Juffermans LJ; van Rossum AC; Niessen HW; Krijnen PA
    Int J Cardiol; 2017 Apr; 232():53-62. PubMed ID: 28087177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor angiogenesis and vascular normalization: alternative therapeutic targets.
    Viallard C; Larrivée B
    Angiogenesis; 2017 Nov; 20(4):409-426. PubMed ID: 28660302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Important signals regulating coronary artery angiogenesis.
    Shoeibi S; Mozdziak P; Mohammadi S
    Microvasc Res; 2018 May; 117():1-9. PubMed ID: 29247718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sudden coronary death caused by pathologic intimal thickening without atheromatous plaque formation.
    Tavora F; Cresswell N; Li L; Ripple M; Fowler D; Burke A
    Cardiovasc Pathol; 2011; 20(1):51-7. PubMed ID: 19913444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Angiogenesis in coronary atherosclerotic plaques and its relationship to plaque stabilization].
    Sun L; Wei LX; Shi HY; Guo AT; Hou N; You LB
    Zhonghua Bing Li Xue Za Zhi; 2003 Oct; 32(5):427-31. PubMed ID: 14633454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.